# BIP CVC Clinical Safety and Performance Study

> **NCT02811380** · PHASE4 · COMPLETED · sponsor: **Bactiguard AB** · enrollment: 36 (actual)

## Conditions studied

- Surgery
- Central Line Associated Blood Stream Infections (CLABSI)

## Interventions

- **DEVICE:** BIP CVC
- **DEVICE:** Uncoated Standard CVC

## Key facts

- **NCT ID:** NCT02811380
- **Lead sponsor:** Bactiguard AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2016-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02811380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02811380, "BIP CVC Clinical Safety and Performance Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02811380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*